Suppr超能文献

成骨不全症中的破骨细胞指数:系统评价与荟萃分析。

Osteoclast indices in osteogenesis imperfecta: systematic review and meta-analysis.

作者信息

Aksornthong Sirion, Patel Priyesh, Komarova Svetlana V

机构信息

Department of Experimental Surgery, McGill University, Montreal, Quebec H3G 1A4, Canada.

Shriners Hospital for Children-Canada, Montreal, Quebec H4A 0A9, Canada.

出版信息

JBMR Plus. 2024 Aug 21;8(11):ziae112. doi: 10.1093/jbmrpl/ziae112. eCollection 2024 Nov.

Abstract

Osteogenesis imperfecta (OI) is a rare bone fragility disorder caused by mutations in genes encoding collagen type I or that affect its processing. Alterations in osteoclasts were suggested to contribute to OI pathophysiology. We aimed to systematically identify studies reporting measures of osteoclast formation and function in patients and mouse models of OI, to quantify OI-induced changes. The systematic search of Medline, Ovid, and Web of Science identified 798 unique studies. After screening, we included 23 studies for meta-analysis, reporting osteoclast parameters in 310 patients with OI of 9 different types and 16 studies reporting osteoclast parameters in 406 animals of 11 different OI mouse models. The standardized mean difference with 95% confidence interval (CI) was used as the effect size, and random-effects meta-analysis was performed. In patients with OI, collagen degradation markers were significantly higher compared with age-matched controls, with an effect size of 1.23 (CI: 0.36, 2.10]. Collagen degradation markers were the most elevated in the 3- to 7-year-old age group and in patients with more severe forms of OI. Bone histomorphometry demonstrated the trends for higher osteoclast numbers (1.16; CI: -0.22, 2.55) and osteoclast surface (0.43; CI: -0.63, 1.49), and significantly higher eroded surface (3.24; CI: 0.51, 5.96) compared with age-matched controls. In OI mice, meta-analysis demonstrated significant increases in collagen degradation markers (1.59; CI: 1.07, 2.11), in osteoclast numbers (0.94; CI: 0.50, 1.39), osteoclast surface (0.73; CI: 0.22, 1.23), and eroded surface (1.31; CI: 0.54, 2.08). The largest differences were in OI mice with the mutations in and genes. There were no differences between males and females in clinical or animal studies. Quantitative estimates of changes in osteoclast indices and their variance for patients with OI are important for planning future studies. We confirmed that similar changes are observed in mice with OI, supporting their translational utility.

摘要

成骨不全症(OI)是一种罕见的骨脆性疾病,由编码I型胶原蛋白的基因突变或影响其加工过程的因素引起。有研究表明破骨细胞的改变促成了OI的病理生理过程。我们旨在系统地识别报告OI患者和小鼠模型中破骨细胞形成和功能指标的研究,以量化OI引起的变化。对Medline、Ovid和Web of Science进行系统检索,共识别出798项独立研究。经过筛选,我们纳入了23项研究进行荟萃分析,这些研究报告了9种不同类型的310例OI患者的破骨细胞参数,以及16项报告11种不同OI小鼠模型的406只动物破骨细胞参数的研究。以95%置信区间(CI)的标准化平均差作为效应量,并进行随机效应荟萃分析。在OI患者中,与年龄匹配的对照组相比,胶原蛋白降解标志物显著更高,效应量为1.23(CI:0.36,2.10)。胶原蛋白降解标志物在3至7岁年龄组以及更严重形式的OI患者中升高最为明显。骨组织形态计量学显示,与年龄匹配的对照组相比,破骨细胞数量(1.16;CI:-0.22,2.55)和破骨细胞表面积(0.43;CI:-0.63,1.49)有升高趋势,侵蚀表面积显著更高(3.24;CI:0.51,5.96)。在OI小鼠中,荟萃分析表明胶原蛋白降解标志物(1.59;CI:1.07,2.11)、破骨细胞数量(0.94;CI:0.50,1.39)、破骨细胞表面积(0.73;CI:0.22,1.23)和侵蚀表面积(1.31;CI:0.54,2.08)均显著增加。差异最大的是 和 基因发生突变的OI小鼠。在临床或动物研究中,雄性和雌性之间没有差异。对OI患者破骨细胞指数变化及其方差的定量估计对于规划未来研究很重要。我们证实,在OI小鼠中观察到了类似的变化,这支持了它们在转化研究中的应用价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cb/11450326/d9e571efa959/ziae112ga1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验